Program in Molecular and Cellular Biosciences

分子和细胞生物科学项目

基本信息

  • 批准号:
    7643233
  • 负责人:
  • 金额:
    $ 25.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This application requests funds to support the training of predoctoral students in the Program in Molecular and Cellular Biosciences (PMCB) at Oregon Health & Science University. This interdisciplinary program brings together 175 faculty members from five basic science departments (Biochemistry and Molecular Biology, Cell and Developmental Biology, Molecular and Medical Genetics, Molecular Microbiology and Immunology, and Physiology and Pharmacology) and affiliated research institutes to provide first- and second-year graduate students with the theoretical and laboratory foundation they require to become successful research scientists. This proposal will support six Ph.D. students out of the 119 currently enrolled in the PMCB for their first two years of training. The 80-member training faculty members in this application are internationally recognized for their expertise in biophysical, molecular, cellular, and developmental approaches to important and compelling biological questions using state-of-the art methodologies. Notably, graduate students also directly participate in ground-breaking translational research, ranging from the development of the first small molecule inhibitor of cancer (Gleevec) to the first liver stem cell therapy, the molecular basis of obesity, and the development of new vaccines for emerging pathogens. Our program offers qualified students a common, rigorous didactic grounding for the first year, and continued grounding as students begin to specialize during their second year. Students also participate in seminar series, program retreats, teaching, and may attend scientific meetings. Students must successfully pass a comprehensive written exam at the end of their first year and a qualifying exam at the end of their second year, in which they prepare and defend an original research proposal. Subsequently, students are formally admitted to one of the five participating departments to conduct a research project leading to the awarding of a Doctorate of Philosophy. Importantly, the dynamic research community at OHSU, combined with the proximity of basic and clinical research facilities, provide a unique opportunity for Ph.D. students to form cross-discipline collaborations during their training and to gain an appreciation of the health-relatedness of the basic science research that they undertake.
描述(由申请人提供):本申请要求资金支持在俄勒冈州健康与科学大学的分子和细胞生物科学(PMCB)计划的博士前学生的培训。该跨学科计划汇集了来自五个基础科学部门(生物化学和分子生物学,细胞和发育生物学,分子和医学遗传学,分子微生物学和免疫学,生理学和药理学)和附属研究机构的175名教师,为第一和第二年的研究生提供他们成为成功的研究科学家所需的理论和实验室基础。该项目将资助6名博士。目前在PMCB注册的119名学生中,有100名学生参加了头两年的培训。该应用程序中的80名培训教师因其在生物物理,分子,细胞和发展方法方面的专业知识而获得国际认可,这些方法使用最先进的方法来解决重要和引人注目的生物学问题。值得注意的是,研究生还直接参与突破性的转化研究,从第一个小分子癌症抑制剂(格列卫)的开发到第一个肝脏干细胞疗法,肥胖的分子基础,以及针对新兴病原体的新疫苗的开发。我们的计划为合格的学生提供了一个共同的,严格的教学接地的第一年,并继续接地作为学生开始专门在他们的第二年。学生还参加研讨会系列,计划务虚会,教学,并可能参加科学会议。学生必须在第一年结束时成功通过综合笔试,并在第二年结束时通过资格考试,在该考试中他们准备并捍卫原始研究提案。随后,学生被正式录取到五个参与部门之一进行研究项目,导致授予哲学博士学位。重要的是,在OHSU的动态研究社区,结合基础和临床研究设施的接近,为博士提供了一个独特的机会。学生在培训期间形成跨学科的合作,并获得他们所从事的基础科学研究的健康相关性的赞赏。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gary Thomas其他文献

Gary Thomas的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gary Thomas', 18)}}的其他基金

Regulation of PPAR alpha by PACS-2 in response to nutrient stress
PACS-2 对 PPAR α 的调节以响应营养胁迫
  • 批准号:
    9284686
  • 财政年份:
    2017
  • 资助金额:
    $ 25.08万
  • 项目类别:
Regulation of TRAIL Induced Apoptosis in Cancer Cells
TRAIL 诱导癌细胞凋亡的调节
  • 批准号:
    8444357
  • 财政年份:
    2011
  • 资助金额:
    $ 25.08万
  • 项目类别:
Regulation of TRAIL Induced Apoptosis in Cancer Cells
TRAIL 诱导癌细胞凋亡的调节
  • 批准号:
    8620615
  • 财政年份:
    2011
  • 资助金额:
    $ 25.08万
  • 项目类别:
Regulation of TRAIL Induced Apoptosis in Cancer Cells
TRAIL 诱导癌细胞凋亡的调节
  • 批准号:
    8236931
  • 财政年份:
    2011
  • 资助金额:
    $ 25.08万
  • 项目类别:
Regulation of TRAIL Induced Apoptosis in Cancer Cells
TRAIL 诱导癌细胞凋亡的调节
  • 批准号:
    8499533
  • 财政年份:
    2011
  • 资助金额:
    $ 25.08万
  • 项目类别:
Regulation of TRAIL Induced Apoptosis in Cancer Cells
TRAIL 诱导癌细胞凋亡的调节
  • 批准号:
    8106890
  • 财政年份:
    2011
  • 资助金额:
    $ 25.08万
  • 项目类别:
Role of PACS proteins in polycystin-2 trafficking and ADPKD
PACS 蛋白在多囊蛋白 2 运输和 ADPKD 中的作用
  • 批准号:
    8005265
  • 财政年份:
    2010
  • 资助金额:
    $ 25.08万
  • 项目类别:
Program in Molecular and Cellular Biosciences
分子和细胞生物科学项目
  • 批准号:
    7084503
  • 财政年份:
    2005
  • 资助金额:
    $ 25.08万
  • 项目类别:
Program in Molecular and Cellular Biosciences
分子和细胞生物科学项目
  • 批准号:
    7252601
  • 财政年份:
    2005
  • 资助金额:
    $ 25.08万
  • 项目类别:
Program in Molecular and Cellular Biosciences
分子和细胞生物科学项目
  • 批准号:
    8098756
  • 财政年份:
    2005
  • 资助金额:
    $ 25.08万
  • 项目类别:

相似海外基金

Molecular and Cellular Regulation of Uterine Morphogenesis
子宫形态发生的分子和细胞调节
  • 批准号:
    10750127
  • 财政年份:
    2024
  • 资助金额:
    $ 25.08万
  • 项目类别:
Molecular Virology/Epidemiology HIV Training in Kazakhstan (MoVE-Kaz)
哈萨克斯坦分子病毒学/流行病学艾滋病毒培训 (MoVE-Kaz)
  • 批准号:
    10689586
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
用于儿科 AML 可测量残留疾病监测的个性化分子检测的临床前验证
  • 批准号:
    10643568
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Molecular Mechanisms Guiding TRIM28 Contribution to Determination
指导 TRIM28 对测定的分子机制
  • 批准号:
    10751859
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Investigating the molecular mechanisms of glycosaminoglycan assembly
研究糖胺聚糖组装的分子机制
  • 批准号:
    10715380
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
心血管事件的分子预测因素和慢性冠状动脉疾病的恢复力
  • 批准号:
    10736587
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Molecular regulation and expression of Trop-2 in advanced prostate cancer: Identifying optimal therapeutic niches
晚期前列腺癌中 Trop-2 的分子调控和表达:确定最佳治疗领域
  • 批准号:
    10735996
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
The impact of early life opioid exposure on the molecular and functional trajectories of septal cell types
生命早期阿片类药物暴露对隔膜细胞类型分子和功能轨迹的影响
  • 批准号:
    10775154
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Molecular mechanisms driving therapy-induced lineage plasticity
驱动治疗诱导的谱系可塑性的分子机制
  • 批准号:
    10730635
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
Elucidating and harnessing the molecular mechanisms of protective clearance in endogenous and engineered phagocytes
阐明和利用内源性和工程化吞噬细胞保护性清除的分子机制
  • 批准号:
    10729935
  • 财政年份:
    2023
  • 资助金额:
    $ 25.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了